Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $27 Million - $30.4 Million
196,150 Added 52.82%
567,486 $87.9 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $111 Million - $128 Million
-829,561 Reduced 69.08%
371,336 $55.4 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $159 Million - $198 Million
1,200,897 New
1,200,897 $162 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $38.3 Million - $45.9 Million
-276,979 Reduced 83.47%
54,862 $8.87 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $28.8 Million - $33.1 Million
214,813 Added 183.56%
331,841 $44.5 Million
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $26 Million - $33.1 Million
-189,217 Reduced 61.79%
117,028 $17.9 Million
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $24.7 Million - $30.6 Million
187,169 Added 157.18%
306,245 $49.6 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $10.2 Million - $12.9 Million
95,208 Added 398.89%
119,076 $16.1 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $266,957 - $303,037
-2,509 Reduced 9.51%
23,868 $2.58 Million
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $2.78 Million - $3.09 Million
26,377 New
26,377 $2.97 Million
Q4 2020

Feb 16, 2021

SELL
$80.49 - $108.67 $22 Million - $29.7 Million
-273,751 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$85.91 - $100.83 $23.5 Million - $27.6 Million
273,751 New
273,751 $24 Million
Q2 2020

Aug 14, 2020

SELL
$73.37 - $98.18 $11.7 Million - $15.6 Million
-159,158 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $8.85 Million - $13.4 Million
-137,243 Reduced 46.3%
159,158 $12.1 Million
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $2.1 Million - $2.63 Million
-29,148 Reduced 8.95%
296,401 $26.2 Million
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $20.5 Million - $24.7 Million
325,549 New
325,549 $24.7 Million
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $23.1 Million - $29.5 Million
-351,171 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $27.1 Million - $31.9 Million
351,171 New
351,171 $28.3 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $33.5 Million - $41.3 Million
-430,636 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $22 Million - $24.5 Million
247,930 Added 135.7%
430,636 $40.7 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $38 Million - $44.9 Million
-422,882 Reduced 69.83%
182,706 $16.9 Million
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $55.7 Million - $74.6 Million
605,588 New
605,588 $57.3 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.